Stock 539561 REMEDIUM LIFECARE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Remedium Lifecare Limited

Equities

539561

INE549S01036

Pharmaceuticals

End-of-day quote Bombay S.E.
Other stock markets
 06:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
84.1 INR -4.97% Intraday chart for Remedium Lifecare Limited -16.07% -16.13%
Apr. 12 Remedium Lifecare Limited Announces Board Changes CI
Feb. 28 Remedium Lifecare Bags Export Order Worth INR1.69 Billion MT

Valuation

Fiscal Period: March 2019 2020 2021 2022 2023
Capitalization 1 55.62 80.28 158.4 498.6 2,655
Enterprise Value (EV) 1 45.59 74.67 255.3 484.2 2,437
P/E ratio 696 x 29 x 33.1 x 46.3 x 48.9 x
Yield - - - - -
Capitalization / Revenue 35 x 2.78 x 0.18 x 0.1 x 0.52 x
EV / Revenue 28.7 x 2.58 x 0.28 x 0.1 x 0.48 x
EV / EBITDA -67.6 x 19.7 x 37.2 x 27.8 x 36.3 x
EV / FCF -117 x -15.3 x -2.47 x 4.37 x 12.8 x
FCF Yield -0.85% -6.54% -40.5% 22.9% 7.82%
Price to Book 1.81 x 2.39 x 4.11 x 10.1 x 25.6 x
Nbr of stocks (in thousands) 100,800 100,800 100,800 100,800 100,800
Reference price 2 0.5518 0.7964 1.571 4.946 26.34
Announcement Date 9/7/19 9/7/20 9/2/21 8/27/22 6/27/23
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net sales 1 3.502 1.591 28.9 900.4 5,048 5,098
EBITDA 1 0.008481 -0.674 3.8 6.854 17.4 67.16
EBIT 1 -0.005815 -0.688 3.75 6.616 17.02 65.65
Operating Margin -0.17% -43.24% 12.97% 0.73% 0.34% 1.29%
Earnings before Tax (EBT) 1 0.1681 0.192 3.749 6.528 15.25 73.96
Net income 1 0.1371 0.08 2.77 4.805 10.78 54.26
Net margin 3.91% 5.03% 9.58% 0.53% 0.21% 1.06%
EPS 2 0.001359 0.000793 0.0275 0.0475 0.1068 0.5382
Free Cash Flow 1 -1.583 -0.389 -4.886 -103.5 110.7 190.6
FCF margin -45.19% -24.45% -16.91% -11.49% 2.19% 3.74%
FCF Conversion (EBITDA) - - - - 636.27% 283.79%
FCF Conversion (Net income) - - - - 1,027.02% 351.26%
Dividend per Share - - - - - -
Announcement Date 9/12/18 9/7/19 9/7/20 9/2/21 8/27/22 6/27/23
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - 96.9 - -
Net Cash position 1 0.16 10 5.61 - 14.4 219
Leverage (Debt/EBITDA) - - - 14.14 x - -
Free Cash Flow 1 -1.58 -0.39 -4.89 -103 111 191
ROE (net income / shareholders' equity) 0.45% 0.26% 8.62% 13.3% 24.5% 70.9%
ROA (Net income/ Total Assets) -0.01% -1.29% 6.01% 1.93% 0.81% 0.6%
Assets 1 -1,213 -6.198 46.06 248.7 1,329 9,112
Book Value Per Share 2 0.3000 0.3100 0.3300 0.3800 0.4900 1.030
Cash Flow per Share 2 0 0.1100 0.0900 0.0800 0.1400 2.170
Capex - - 2.44 0.39 0.5 0.43
Capex / Sales - - 8.45% 0.04% 0.01% 0.01%
Announcement Date 9/12/18 9/7/19 9/7/20 9/2/21 8/27/22 6/27/23
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
REMEDIUM LIFECARE LIMITED Stock Remedium Lifecare Limited
-16.13% 101M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+30.38% 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.51% 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.36% 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.30% 329B
ABBVIE INC. Stock AbbVie Inc.
+3.73% 284B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.70% 240B
NOVARTIS AG Stock Novartis AG
+8.78% 208B
ROCHE HOLDING AG Stock Roche Holding AG
-7.93% 200B
AMGEN INC. Stock Amgen Inc.
+7.68% 166B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 539561 Stock
  4. Financials Remedium Lifecare Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW